Determining the Impact of Penicillin in Latent RHD: The GOAL Trial

PHASE2UnknownINTERVENTIONAL
Enrollment

807

Participants

Timeline

Start Date

June 26, 2018

Primary Completion Date

November 30, 2020

Study Completion Date

November 30, 2020

Conditions
Rheumatic Heart Disease in ChildrenLatent Rheumatic Heart DiseaseRheumatic Heart DiseaseHeart Diseases
Interventions
DRUG

intramuscular benzathine penicillin G (BPG) prophylaxis

Intramuscular BPG prophylaxis (600,000 IU for children \<30kg, 1.2 million IU for children ≥30kg), every 28 days.

Trial Locations (1)

20010

GOAL Office, Gulu

All Listed Sponsors
collaborator

Thrasher Research Fund

OTHER

collaborator

University of Cape Town

OTHER

collaborator

Uganda Heart Institute

OTHER

collaborator

Karp Family Foundation

UNKNOWN

collaborator

Gift of Life International

OTHER

collaborator

Murdoch Childrens Research Institute

OTHER

lead

Children's National Research Institute

OTHER